Literature DB >> 25792639

Future trends in cystic fibrosis demography in 34 European countries.

Pierre-Régis Burgel1, Gil Bellis2, Hanne V Olesen3, Laura Viviani4, Anna Zolin4, Francesco Blasi5, J Stuart Elborn6.   

Abstract

Median survival has increased in people with cystic fibrosis (CF) during the past six decades, which has led to an increased number of adults with CF. The future impact of changes in CF demographics has not been evaluated. The aim of this study was to estimate the number of children and adults with CF in 34 European countries by 2025. Data were obtained from the European Cystic Fibrosis Society Patient Registry. Population forecasts were performed for countries that have extensive CF population coverage and at least 4 years of longitudinal data by modelling future entering and exiting flows in registry cohorts. For the other countries, population projections were performed based on assumptions from knowledge of current CF epidemiology. Western European countries' forecasts indicate that an increase in the overall number of CF patients by 2025, by approximately 50%, corresponds to an increase by 20% and by 75% in children and adults, respectively. In Eastern European countries the projections suggest a predominant increase in the CF child population, although the CF adult population would also increase.It was concluded that a large increase in the adult CF population is expected in the next decade. A significant increase in adult CF services throughout Europe is urgently required.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 25792639     DOI: 10.1183/09031936.00196314

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  57 in total

1.  Lessons from the on-site quality audit of data transmitted to the French cystic fibrosis registry.

Authors:  Nadine Pellen; Laëtitia Guéganton; Dominique Pougheon Bertrand; Gilles Rault
Journal:  Orphanet J Rare Dis       Date:  2018-02-08       Impact factor: 4.123

2.  Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis.

Authors:  Pierre-Régis Burgel; Gil Bellis; J Stuart Elborn
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

3.  Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.

Authors:  Abaigeal D Jackson; Andrew L Jackson; Godfrey Fletcher; Gerardine Doyle; Mary Harrington; Shijun Zhou; Fiona Cullinane; Charles Gallagher; Edward McKone
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

Review 4.  Cystic fibrosis: a clinical view.

Authors:  Carlo Castellani; Baroukh M Assael
Journal:  Cell Mol Life Sci       Date:  2016-10-05       Impact factor: 9.261

5.  Cystic fibrosis heterozygosity: Carrier state or haploinsufficiency?

Authors:  David Fisman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-28       Impact factor: 11.205

Review 6.  Cystic Fibrosis.

Authors:  Susanne Naehrig; Cho-Ming Chao; Lutz Naehrlich
Journal:  Dtsch Arztebl Int       Date:  2017-08-21       Impact factor: 5.594

Review 7.  Tackling the increasing complexity of CF care.

Authors:  Gregory S Sawicki; Christopher H Goss
Journal:  Pediatr Pulmonol       Date:  2015-10

Review 8.  Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.

Authors:  Jean Tyrrell; Máire Callaghan
Journal:  Microbiology (Reading)       Date:  2015-12-04       Impact factor: 2.777

Review 9.  [Cystic fibrosis : A new disease pattern in adult medicine].

Authors:  D Staab; C Schwarz
Journal:  Internist (Berl)       Date:  2018-11       Impact factor: 0.743

10.  Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.

Authors:  Freddy Frost; Matthew Shaw; Dilip Nazareth
Journal:  Cochrane Database Syst Rev       Date:  2019-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.